|
Table
16 Host-mediated antitumor
polysaccarides in REISHI |
|||||||
|
Glycans |
Name |
Yield
(% for dry bases) |
MW
(MW x 10-4) |
Dose,
ip (mg/kg x days) |
Sarcoma
180/mice |
||
|
Inhibition |
Complete
regression (T/Control) |
ID50
(mg/kg) |
|||||
|
Water-soluble |
|
|
|
|
|
|
|
|
FI-1a-beta |
Beta-Glucan |
0.002 |
100 |
50
x 1 |
100 |
5/5 |
2.8 |
|
FA-1a-beta |
Glucurono-beta-glucan |
0.005 |
35~45 |
40
x 1 |
100 |
5/5 |
22.2 |
|
Water-insoluble |
|
|
|
|
|
|
|
|
FII-1 |
Hetero-beta-glucan |
0.4 |
1~3 |
100
x 1 |
100 |
5/5 |
8.3 |
|
FIII-1a,
b |
Xylo-beta-glucan |
8.6 |
200 |
100
x 1 |
85 |
4/5 |
6.5 |
|
FIII-2a,
b |
Xylomanno-beta-glucan |
0.8 |
200 |
100
x 1 |
100 |
5/5 |
6.7 |
|
FIII-3a |
Manno-beta-glucan |
0.4 |
3~6 |
100
x 1 |
100 |
5/5 |
12.8 |
|
Dietary
fiver |
|
|
|
|
|
|
|
|
FIV-2 |
Xylomanno-beta-glucan |
2.4 |
6 |
100
x 1 |
66 |
2/5 |
42.5 |
|
FV-1 |
Xylomanno-beta-glucan |
1.6 |
16 |
100
x 1 |
95 |
5/5 |
34.1 |